Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

David R. Bangsberg

Research output: Contribution to journalArticlepeer-review

450 Scopus citations

Fingerprint

Dive into the research topics of 'Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression'. Together they form a unique fingerprint.

Medicine & Life Sciences